FOR IMMEDIATE RELEASE Media Contact: Chiara Canzi Chief Communications Officer [email protected] (434) 249-5930 www.medaditus.org Med Aditus International Announces Appointment of Robert A. Blouin as President & Chief Executive Officer and Launch of Subsidiary, Med Aditus Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, NC, (November 16, 2023)
FOR IMMEDIATE RELEASE Media Contact: Chiara Canzi Chief Communications Officer [email protected] (434) 249-5930 www.medaditus.org Med Aditus Announces the Appointment of Yves Ribeill and Bob Blouin to Board of Directors RESEARCH TRIANGLE PARK, NC, (November 09, 2022) – Med Aditus International, Inc. is pleased to announce the
RESEARCH TRIANGLE PARK, NC, (January 11, 2021) – Med Aditus International, Inc. is pleased to announce the appointment of three new members to its Board of Directors. Joining the board are Ngozi Bell, P. Kay Wagoner, and Steve Hammond. “It is my privilege and pleasure
RESEARCH TRIANGLE PARK, NC, (December 2, 2020) – Med Aditus International, Inc. and Rymedi announce a cooperation agreement aimed at fostering access to high-quality medicines in sub-Saharan African countries while transforming the region’s emerging pharmaceutical sector into a world-class, sustainable ecosystem. The agreement, in the form
RESEARCH TRIANGLE PARK, NC, (September 24, 2020) – Today marks the official launch of Med Aditus International, Inc., a nonprofit seeking to make quality, life-saving medicines available at affordable prices to patients in sub-Saharan Africa. Headquartered in the Research Triangle Park, North Carolina, Med Aditus was
